HBW Insight is part of Pharma Intelligence UK Limited

This site is operated by Pharma Intelligence UK Limited, a company registered in England and Wales with company number 13787459 whose registered office is 5 Howick Place, London SW1P 1WG. The Pharma Intelligence group is owned by Caerus Topco S.à r.l. and all copyright resides with the group.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By

UsernamePublicRestriction

E.l.f. Beauty’s Q3 Sales Jump 49% With ‘A Lot’ Of Runway Ahead, CEO Says

Executive Summary

Oakland, CA-based e.l.f. Beauty is significantly increasing its full fiscal year 2023 sales estimate, predicting 38%-39% growth after third quarter sales soared 49% to reach $146.5m. CEO Tarang Amin discusses the white space opportunities contributing to a bullish outlook even beyond the fiscal year.

You may also be interested in...



‘Lipstick Effect’ Holding In 2023 Despite Continuing Price Escalation – Catalina Marketing

Consumers continued to spend more on beauty products in January 2023 in US mass retail doors despite rising prices across face makeup, eye makeup and lipstick segments, according to market intelligence and consulting firm Catalina Marketing.

P&G Marketing Laces Up For Another Super Bowl Appearance, Along With Rookie E.l.f. Beauty

E.l.f. will launch its first TV spot during Super Bowl LVII, while FENTY Beauty has introduced a limited-edition makeup collection in anticipation of Rihanna headlining the halftime show. Veteran P&G will have a strong presence again this year, both during the game and in the lead-up on social media.

E.l.f. Continues To Win With Value Pricing, Youth Appeal; 33% Growth In Second Quarter

The firm is targeting 22%-24% net sales growth for the fiscal full year ended 31 March 2023 after reporting its 15th consecutive quarter of growth.

Topics

Latest Headlines
See All
UsernamePublicRestriction

Register

RS153337

Ask The Analyst

Ask the Analyst is free for subscribers.  Submit your question and one of our analysts will be in touch.

Your question has been successfully sent to the email address below and we will get back as soon as possible. my@email.address.

All fields are required.

Please make sure all fields are completed.

Please make sure you have filled out all fields

Please make sure you have filled out all fields

Please enter a valid e-mail address

Please enter a valid Phone Number

Ask your question to our analysts

Cancel